APPLICATION FOR AWARD BEGINNING NOVEMBER 1, 2017

The Pichichero Family Foundation and the PIDS Education and Research Foundation seek to encourage increased innovative and significant research to improve or develop new vaccines and immunotherapeutics for children.  To that end, applications for two-year grants are available for PIDS members at any level in their professional career and all members of PIDS are encouraged to apply.  With federal support often leaving many worthy projects unfunded in pediatric infectious diseases, these grants will support projects similar to a K award for young investigators or R03 awards for investigators in mid- or mature career with a budget of $50,000 per year for a total of $100,000 that includes an 8% allocation to indirect overhead costs for the awardee’s institution.  Clinical, translational and basic research projects will be responsive to the request for proposals. Proposals involving pathogenesis of infections that have a clear tie to vaccine immunobiology will be considered. Physician scientists will be given priority in the scoring of proposals but exceptional proposals from any member of PIDS will be considered.  Applications by members of sister pediatric infectious disease societies (e.g. ESPID, SLIPE, ASPID, WSPID, AfSPID and ANZID) will be accepted and considered as long as the applicant is also a member of PIDS.  Affirmation that the proposal submitted is not and will not be duplicative with any application submitted to any other granting federal or private agency is required.  A letter of support by the Department Chair or Division Chief, as appropriate, stating that the awardee will have at least 50% protected time to conduct research is also required.  All applications will be scored by the PIDS Research Affairs Committee according to U.S. National Institutes of Health methodology similar to K and R awards. The deadline for submission is Monday, June 5, 2017 and announcement of successful applications will be made at the annual IDWeek meeting in the Fall. Click here for more details.